In 1885 Ehrlich (1) discovered that when coerulein-s, an acidic dye, was injected subcutaneously into experimental animals, various organs were stained but the brain was left entirely uncolored. In 1913 Goldman (2) performed a series of now classical experiments which established the concept of the blood-brain barrier. After injecting trypan blue intravenously, he found that vital staining occurred in all the tissues except the brain, which remained uncolored except for the choriod plexus.In all probability, most substances penetrate the central nervous system to some degree. In addition, the blood-brain barrier is not uniform throughout the brain since well defined areas such as the hypophysis, infundibulum, area postrema, and others are readily stained by trypan blue from the circulation. However, the fact remains that many substances, i.e. electrolyte, colloid, vital dye, protein, etc., penetrate the central nervous system parenchyma with great difficulty, whereas the exchange of these substances between vessels and tissues in the rest of the body occurs much more freely. The blood-brain barrier is, in effect, a rate phenomenon and not a true barrier (3). Accumulative evidence indicates that it is a composite mechanism regulating the uptake of materials by the CNS; biochemical and physiological as well as anatomical factors all contribute to its function (eft reference 4).The role of the blood-brain barrier in the humoral spread of neurotropic viruses, and in particular poliovirus, to the CNS has long been a matter for speculation. In infected individuals, only rarely does poliovirus reach the CNS where it produces the paralysis that characterizes overt disease. The portal of entry is the oropharynx and lower intestinal tract; from these initial and/or *